384 related articles for article (PubMed ID: 15515743)
1. Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease.
Taki J; Yoshita M; Yamada M; Tonami N
Ann Nucl Med; 2004 Sep; 18(6):453-61. PubMed ID: 15515743
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
Orimo S
Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
[TBL] [Abstract][Full Text] [Related]
3. 123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders.
Rascol O; Schelosky L
Mov Disord; 2009; 24 Suppl 2():S732-41. PubMed ID: 19877202
[TBL] [Abstract][Full Text] [Related]
4. [The clinical significance of MIBG myocardial scintigraphy in Parkinson disease].
Orimo S
Brain Nerve; 2012 Apr; 64(4):403-12. PubMed ID: 22481513
[TBL] [Abstract][Full Text] [Related]
5. (123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in α-synucleinopathies.
Orimo S; Yogo M; Nakamura T; Suzuki M; Watanabe H
Ageing Res Rev; 2016 Sep; 30():122-33. PubMed ID: 26835846
[TBL] [Abstract][Full Text] [Related]
6. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K
J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056
[TBL] [Abstract][Full Text] [Related]
7. On the Utility of MIBG SPECT/CT in Evaluating Cardiac Sympathetic Dysfunction in Lewy Body Diseases.
Odagiri H; Baba T; Nishio Y; Iizuka O; Matsuda M; Inoue K; Kikuchi A; Hasegawa T; Aoki M; Takeda A; Taki Y; Mori E
PLoS One; 2016; 11(4):e0152746. PubMed ID: 27055151
[TBL] [Abstract][Full Text] [Related]
8. [Early alteration of adrenergic cardiac function in parkinsonisms with Lewy bodies].
Jiménez-Hoyuela García JM; Campos Arillo V; Rebollo Aguirre AC; Gómez Doblas JJ; Gutiérrez Hurtado A
Rev Esp Med Nucl; 2005; 24(2):93-100. PubMed ID: 15745679
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.
Giannoccaro MP; Donadio V; Giannini G; Devigili G; Rizzo G; Incensi A; Cason E; Calandra-Buonaura G; Eleopra R; Cortelli P; Liguori R
Parkinsonism Relat Disord; 2020 Dec; 81():48-53. PubMed ID: 33049589
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders.
King AE; Mintz J; Royall DR
Mov Disord; 2011 Jun; 26(7):1218-24. PubMed ID: 21480373
[TBL] [Abstract][Full Text] [Related]
11. 123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder.
Miyamoto T; Miyamoto M; Suzuki K; Nishibayashi M; Iwanami M; Hirata K
Sleep; 2008 May; 31(5):717-23. PubMed ID: 18517041
[TBL] [Abstract][Full Text] [Related]
12. Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies.
Kashihara K; Ohno M; Kawada S; Okumura Y
J Nucl Med; 2006 Jul; 47(7):1099-101. PubMed ID: 16818943
[TBL] [Abstract][Full Text] [Related]
13. A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies.
Yoshita M; Taki J; Yamada M
J Neurol Neurosurg Psychiatry; 2001 Nov; 71(5):583-8. PubMed ID: 11606666
[TBL] [Abstract][Full Text] [Related]
14. [Decreased myocardial uptake of meta-iodobenzylguanidine in an autopsy-confirmed case of corticobasal degeneration with Lewy bodies restricted to the sympathetic ganglia].
Mori K; Iwasaki Y; Ito M; Mimuro M; Yoshida M
Rinsho Shinkeigaku; 2012; 52(6):405-10. PubMed ID: 22790801
[TBL] [Abstract][Full Text] [Related]
15. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy.
Braune S; Reinhardt M; Schnitzer R; Riedel A; Lücking CH
Neurology; 1999 Sep; 53(5):1020-5. PubMed ID: 10496261
[TBL] [Abstract][Full Text] [Related]
16. Myocardial MIBG scintigraphy in genetic Parkinson's disease as a model for Lewy body disorders.
Gabilondo I; Llorens V; Rodriguez T; Fernández M; Concha TP; Acera M; Tijero B; Murueta-Goyena A; Del Pino R; Cortés J; Gómez-Esteban JC
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):376-384. PubMed ID: 30324423
[TBL] [Abstract][Full Text] [Related]
17. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease.
Orimo S; Amino T; Itoh Y; Takahashi A; Kojo T; Uchihara T; Tsuchiya K; Mori F; Wakabayashi K; Takahashi H
Acta Neuropathol; 2005 Jun; 109(6):583-8. PubMed ID: 15933869
[TBL] [Abstract][Full Text] [Related]
18. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp.
Taki J; Nakajima K; Hwang EH; Matsunari I; Komai K; Yoshita M; Sakajiri K; Tonami N
Eur J Nucl Med; 2000 May; 27(5):566-73. PubMed ID: 10853813
[TBL] [Abstract][Full Text] [Related]
19. Recent developments in innervation imaging using iodine-123-metaiodobenzylguanidine scintigraphy in Lewy body diseases.
Treglia G; Cason E; Gabellini A; Giordano A; Fagioli G
Neurol Sci; 2010 Aug; 31(4):417-22. PubMed ID: 20221656
[TBL] [Abstract][Full Text] [Related]
20. Is 123I-MIBG Scintigraphy Beneficial or Excessive for the Diagnosis of Parkinson's Disease in the Early Phase?
Ikeda T; Ikenoshita S; Sakamoto F; Shiraishi S; Nakahara K; Masuda T; Yamashita S
Neurodegener Dis; 2019; 19(2):88-95. PubMed ID: 31715596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
